Ep. 78 - Dr. John LaMattina on Balancing Innovation, Medicine, and Drug Prices
The Economics Review

Ep. 78 - Dr. John LaMattina on Balancing Innovation, Medicine, and Drug Prices

2022-08-20

Dr. John LaMattina is the former President of Global Research and Development at Pfizer, overseeing the drug discovery and development efforts of over 13,000 colleagues across the world. He is now a Senior Partner and a member of the Board of Directors of PureTech Health. Holding a Ph.D. from the University of New Hampshire in Organic Chemistry, his latest book is titled Pharma and Profits: Balancing Innovation, Medicine, and Drug Prices.

Comments (3)

More Episodes

All Episodes>>

Get this podcast on your phone, Free

Create Your Podcast In Minutes

  • Full-featured podcast site
  • Unlimited storage and bandwidth
  • Comprehensive podcast stats
  • Distribute to Apple Podcasts, Spotify, and more
  • Make money with your podcast
Get Started
It is Free